Skip Navigation
Search Menu
Find an Expert

 


Cynthia L Sears, M.D.

Photo of Dr. Cynthia L Sears, M.D.

Professor of Medicine

Female

Expertise: Infectious Disease, Infectious Diseases

Request an Appointment

I live in Maryland

410-955-1725
Request an appointment through MyChart!

I live outside of Maryland

410-464-6641
Request Appointment

I live outside of the United States

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital
Appointment Phone: 410-955-1725

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map

Contact for Research Inquiries

Johns Hopkins University
1550 Orleans Street
Suite 1M05
Baltimore, MD 21287 map

Background

My laboratory focuses on the pathogenesis of colon disease by enteric bacteria using enterotoxigenic Bacteroides fragilis (ETBF) as a model for inducing colon inflammation. We identified the B. fragilis toxin gene (bft), purified the protein (BFT) and defined its mechanism of action in vitro. More recently, we established in vivo models of ETBF colitis and colon tumorigenesis. Using these models, we have identified that ETBF induce selective Stat3/Th17 immune responses in the colon and that these pathways, at least in part, contribute to colon tumorigenesis. Our data were the first to report this mechanism for inflammation-induced endogenous colon tumor induction in response to colon colonization with a human commensal (up to 40% of ETBF-colonized humans are asymptomatic). We are extending this work to human studies to understand the microbial contribution to colitis and colon cancer pathogenesis. Our studies include the molecular mechanisms by which BFT and ETBF induce colon carcinogenesis including identifying the BFT receptor, defining BFT-induced activation of colonic epithelial signaling pathways, determining the immunologic  determinants  of  colon  carcinogenesis  and  establishing  the  genetic  and  epigenetic mutations contributing to colon tumor induction and promotion stimulated by ETBF through BFT.

Most relevant to the current application

  1. Chambers FG, Koshy SS, Saidi R, Clark DP, Sears CL. . Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infec. Immun. . 1997;(65):3561- 3570. PMCID: Prior to April 2008.
  2. Wu S, Lim K-C, Huang J, Saidi SF, Sears CL. . The Bacteroides fragilis toxin cleaves the Zonula Adherens Protein, E-cadherin. Proc. Natl. Acad. Sci. USA. . 1998;(95):14979- 14984. PMCID: Prior to April 2008.
  3. Riegler M, Lotz M, Sears CL, Pothoulakis C, Castagliuolo I, Wang CC, Sedivy R, Sogukoglu T, Cosentini E, Bischof G, Feil W, Teleky B, Hamilton G, LaMont JT and Wenzl E. . Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut . 1999;(44):504-510. PMCID: Prior to April 2008.
  4. Wu S, Morin PJ, Maouyo D, Sears CL. . Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation Gastroenterology. 2003;(124):392-400. PMCID: Prior to April 2008.
  5. Wu S, Powell J, Mathioudakis N, Kane S, Fernandez E, Sears CL. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 (IL-8) through mitogen activated protein kinases and a tyrosine kinase-regulated Nuclear Factor-?? pathway Infec Immun . 2004;(72):5832-5839. PMCID: Prior to April 2008.
  6. Wu S, Shin JW, Cohen M, Zhang G, Sears CL. . The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infection & Immunity Infection & Immunity . 2006;(74):5832-5390. PMCID: Prior to April 2008.
  7. Wu S, Zhang M, Franco AA, Rhee K, Sears CL. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and activates E-cadherin cleavage dependent on cellular γsecretase. J Cell Science . 2007;(120):1944-1952. PMCID: Prior to April 2008.
  8. Sears CL, Islam S, Saha A, Arjumand M, Alam NH, Faruque ASG, Salam MA, Shin J, Hecht D, Weintraub A, Sack RB, Qadri F. Association of Enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clinical Infect Dis . 2008;(47):797-803. PMCID: 3045827.
  9. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of Thelper type 17 T cell responses. Nature Medicine. 2009;(15):1016-1022. PMCID: 3034219.
  10. Sears CL. Enterotoxigenic Bacteroides fragilis: A Rogue among Symbiotes. Clinical Microbiology Reviews. 2009;(22):349-369. PMCID: 2963065.
  11. Rhee KJ, Wu S, Wu X, Huso DL, Karim B, Franco AA, Rabizadeh S, Golub J, Mathews LE, Shin J, Sartor RB, Golenbock D, Hamad, A, Gan CM, Housseau F, Sears CL. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57Bl/6 mice. Infec Immun . 2009;(77):1708-1718. PMCID: 2663167.
  12. Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, Casero RA. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Science 108:15354-9, 2011/
  13. Wick EC, Leblanc RE, Ortega G, Robinson C, Platz E, Pardoll DM, Iacobuzio-Donahue C, Sears CL. Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia. Inflamm Bowel Dis 18:1267-74, 2012. PMCID:3266961
  14. O’Hagan HM, Wang W, Sen S, Destefano Shields C, Lee SS, Zhang YW, Clements EG, Cai Y, Van Neste L, Easwaran H, Casero RA, Sears CL, Baylin SB. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and Polycomb members to promoter CpG islands. Cancer Cell 15:606-619, 2011. PMCID:3220885
  15. Dejea C, Wick E, Sears CL. Bacterial oncogenesis in the colon. Future Microbiology 8(4):445-460, 2013. PMCID (in progress).

Ongoing Research Support

R01CA151393

Sears

09/02/10 - 07/31/15

NIH/NCI Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis. This project will test whether detection of ETBF and/or the colon immune response to ETBF in humans provide new, easier approaches to the prevention of the morbidity and mortality due to colon cancer.(PI)

 

 

R01CA151325

 

 

Sears

 

 

07/06/10 - 04/30/15

NIH/NCI Mechanisms of TH17 Inflammation-Induced Colon Carcinogenesis. This project will study the immune and genetic mechanisms by which a newly recognized common human stool bacterium called enterotoxigenic Bacteroides fragilis (ETBF) triggers colon tumors in mice, providing new insights into how colon cancer develops and potentially new approaches to colon cancer therapy. (PI)

Sears/Pardoll

04/22/13 - 04/22/15

Merieux Institute Induction of Human Colon Cancer by BFT producing Bacteroides Species. Induction of Human Colon Cancer by BFT producing Bacteroides Species The goal of this project is to validate the association of bft-expressing Bacteroides species with CRC and further, to identify targets for development of sensitive and specific diagnostics to identify patients at potential high risk for CRC. (PI)

R21CA170492

Sears

07/01/12 - 06/30/14

NIH/NCI Microbial Induction of Colon Cancer and Mechanisms. This project will integrate microbiota, immunologic and metabolomic data to identify novel biomarkers with potential to enhance the prevention and detection of human colon cancer.(PI)

SIIME Award

Sears/Wick

07/01/12 - 06/30/14

SWAMI Johns Hopkins Swami Institute for Intl. Medical Edu. The goal of this project is to prospectively study the role of the microbiome and enterotoxigenic Bacteroides fragilis (ETBF) in CRC in Kuala Lumpur, Malaysia.(Co-Investigator)

R01CA179440                        Sears                                                                                            07/01/13-06/30/18

NIH                                                                                         

GPR35: Role in Colonic Inflammation and Oncogenesis

This project test the hypothesis that GPR35, known to be highly expressed in the colon and previously linked to gastric cancer induction, is the CEC receptor hijacked by BFT and a critical contributor to colon carcinogenesis, thereby, providing a direct molecular link between a common microbiota member and CRC pathogenesis.

 

Completed Research Support

5R01 DK080817-05

Sears

05/01/08 - 02/28/13

NIH/NIDDK Mechanisms of Interleukin-17 Inflammation Induced by Bacteroides Fragilis

5R01 DK045496-19

Sears

08/20/93 - 06/30/12

NIH/NIDDK Physiology and Cloning of B Fragilis Enterotoxin

5U54 CA091409-10

Nelson

07/13/01 - 08/31/11

NIH/NCI Howard/Hopkins Cancer Center Partnership - Project 1- Gut Flora and Colon Cancer in African Americans (Co-Investigator)

 

2T32 AI007291-16

 

Gebo

 

08/01/06 - 07/31/11

NIH/NIAID Research Training in Microbial Diseases(Co-Investigator)

 

R43A1092976

Sears/Pardoll

08/01/11 - 07/31/13

L2 Diagnostics (sub contract)Induction Of Human Colon Cancer by BFT producing Bac SpeciesThe goal of this project is development of a real-time polymerase chain for quantification of enterotoxigenic Bacteroides fragilis (ETBF) in human stool samples.(PI)

R01CA098454

Casero

01/01/09 - 12/31/13

NIH/NCI Polyamine Oxidases as Antitumor TargetsThe goal of this project is to understand how polyamine oxidases contribute to oncogenesis. ETBF-infected mice are used as one model in this grant.(Co-Investigator)

 

...read more

Titles

  • Professor of Medicine
  • Professor of Oncology

Departments / Divisions

Education

Degrees

  • MD, Jefferson Medical College of Thomas Jefferson University (1977)

Board Certifications

  • American Board of Internal Medicine / Infectious Disease (1986)
  • American Board of Internal Medicine / Internal Medicine (1980)

Research & Publications

Research Summary


Expert in foodborne and enteric infections and has studied the pathogenesis of enterotoxigenic Bacteroides fragilis (ETBF) both in the laboratory and in clinical settings over the past nearly 20 years.  Scientific work has been funded continuously by the NIH since 1993.  Presently focusing on mouse and human studies to define how ETBF and the colonic microbiota induce chronie colonic inflammation and colon cancer.

Activities & Honors

Professional Activities

  • Associate Editor, Clinical Infectious Deiseases, 2000
  • President, Anaerobe Society of the Americas

Videos & Media

Recent News Articles and Media Coverage

Biofilm Holds Clues to Colon Cancer, Inside Tract (Summer, 2016)

Is this you? Edit Profile